The Evolution of Target IOP

Carlos Buznego MD, Inder Paul Singh, MD, Jason Bacharach MD

Show Description +

Inder Paul Singh, MD; Carlos Buznego, MD; and Jason Bacharach, MD, discuss how target IOP and the options for achieving it have evolved. What are some key considerations?

Posted: 1/13/2020

Up Next

Name: The Evolution of Target IOP
Uploaded: 2020-01-13T20:43:00+00:00
Description: Inder Paul Singh, MD; Carlos Buznego, MD; and Jason Bacharach, MD, discuss how target IOP and the options for achieving it have evolved. What are some key considerations?

Defining Success in Glaucoma Management

Ehsan Sadri, MD, Inder Paul Singh, MD, Manjool Shah, MD

More Choices in Prostaglandin Analogues

Gregory Katz, MD, Inder Paul Singh, MD

New Horizons in Drug Delivery

Arsham Sheybani, MD, Inder Paul Singh, MD, Jacob W. Brubaker, MD

Targeting the Conventional Outflow System

Inder Paul Singh, MD, Mark J. Gallardo, MD

The Diagnostic Value of Corneal Hysteresis

Davinder Grover, MD, Inder Paul Singh, MD

The Importance of Understanding Mechanism of Action

I. Paul Singh, MD, Jacob W. Brubaker, MD, Jason Bacharach, MD

Addressing Ocular Surface Disease

Christopher Starr, MD, Inder Paul Singh, MD, Sumitra S. Khandelwal, MD

The Evolution of Target IOP

Carlos Buznego MD, Inder Paul Singh, MD, Jason Bacharach MD

Back to All Videos

The Evolution of Target IOP

Carlos Buznego MD, Inder Paul Singh, MD, Jason Bacharach MD

Inder Paul Singh, MD; Carlos Buznego, MD; and Jason Bacharach, MD, discuss how target IOP and the options for achieving it have evolved. What are some key considerations?

Posted: 1/13/2020

Please log in to leave a comment.

Comments

Emmy Ray

5 years ago

Giving the patient time is so key to digest their diagnosis and then coming back to see another pressure point in their day is brilliant.

Series:

Dose and Delivery

The Evolution of Target IOP

Up Next

The Evolution of Target IOP

Comments